Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nexien BioPharma Inc (NXEN)
OTHER OTC:NXEN
Holding NXEN?
Track your performance easily
NXEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.05
Previous Close$0.02
Volume8.10K
Average Volume (3M)20.78K
Market Cap
$1.42M
Enterprise Value$1.56M
Total Cash (Recent Filing)$68.99K
Total Debt (Recent Filing)$213.00K
Price to Earnings (P/E)―
Beta-0.84
Next Earnings
Nov 14, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding67,472,196
10 Day Avg. Volume22,199
30 Day Avg. Volume20,783
Standard Deviation0.48
R-Squared0.00656
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
19.34% Insiders
0.12% Other Institutional Investors
80.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NXEN FAQ
What was Nexien BioPharma Inc’s price range in the past 12 months?
Nexien BioPharma Inc lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.
What is Nexien BioPharma Inc’s market cap?
Currently, no data Available
When is Nexien BioPharma Inc’s upcoming earnings report date?
Nexien BioPharma Inc’s upcoming earnings report date is Nov 14, 2018 which is 2205 days ago.
How were Nexien BioPharma Inc’s earnings last quarter?
Currently, no data Available
Is Nexien BioPharma Inc overvalued?
According to Wall Street analysts Nexien BioPharma Inc’s price is currently Overvalued.
Does Nexien BioPharma Inc pay dividends?
Nexien BioPharma Inc does not currently pay dividends.
What is Nexien BioPharma Inc’s EPS estimate?
Nexien BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexien BioPharma Inc have?
Nexien BioPharma Inc has 70,772,194 shares outstanding.
What happened to Nexien BioPharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nexien BioPharma Inc?
Currently, no hedge funds are holding shares in NXEN
---
Nexien BioPharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-77.54%
Trailing 12-Months
Company Description
Nexien BioPharma Inc
Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. It also invests in companies with technologies or medications focused on cannabinoid-based research. The company was founded in 1952 and is headquartered in Glendale, CO.
---
Technical Analysis
---